# K192725: Cytal Wound Matrix 3-Layer

- Pathway: 510(k) (Special)
- Applicant: Acell, Inc.
- Decided: Oct 25, 2019 after 28 days
- Product code: KGN (Wound Dressing With Animal-Derived Material(S))
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K921895 (1992). 27 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 29 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K152721: Cytal Wound Matrix, Acell, Inc. (2015) Summary page 4.

## Most influential descendants
- K241724: Cytal® Wound Matrix; Cytal® Burn Matrix (2024), 0 descendants of its own

## Indications for use
Cytal® Wound Matrix 3-Layer is intended for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, and skin tears), and draining wounds. The device is intended for one-time use.

Source page: https://510kreport.com/device/K192725
Methodology: https://510kreport.com/methodology